Anika to Issue Second Quarter 2020 Financial Results and Business Highlights on Thursday, July 30
July 16 2020 - 4:05PM
Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint
preservation, restoration and regenerative solutions company with
products across the orthopedic early intervention continuum of
care, today announced that the Company plans to issue its second
quarter 2020 financial results after the close of the market on
Thursday, July 30, 2020 and hold its investor conference call on
the same day, Thursday, July 30, 2020, at 5:00 p.m. ET to discuss
its financial results, business highlights, and outlook.
The conference call can be accessed by dialing 1-855-327-6837
(toll-free domestic) or 1-631-891-4304 (international) and
providing the conference ID number 10010333. A live audio webcast
will be available in the "Investor Relations" section of Anika's
website, www.anikatherapeutics.com. An accompanying slide
presentation also can be accessed via the Anika Therapeutics
website. The call will be archived and accessible on the same
website shortly after its conclusion.
About Anika Therapeutics
Anika Therapeutics, Inc. (NASDAQ: ANIK), is a global, integrated
joint preservation, restoration and regenerative solutions company
based in Bedford, Massachusetts. Anika is committed to delivering a
diverse array of products to improve the lives of patients, with a
focus on osteoarthritis pain management, sports medicine and joint
preservation, restoration and regeneration. The Company has close
to three decades of global expertise commercializing innovative
products across the orthopedic early intervention continuum of
care. For more information about Anika, please visit
www.anikatherapeutics.com.
For Investor Inquiries: Anika Therapeutics, Inc. Sylvia Cheung,
781-457-9000 Chief Financial Officer
investorrelations@anikatherapeutics.com |
For Media Inquiries: W2O Group Rachel Girard,
617-379-6760rgirard@w2ogroup.com |
Anika Therapeutics (NASDAQ:ANIK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Anika Therapeutics (NASDAQ:ANIK)
Historical Stock Chart
From Apr 2023 to Apr 2024